Lyell Immunopharma is securing private placement funds to support its continued growth.
1 report, 1 independent
Updated Jul 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Lyell Immunopharma is securing private placement funds to support its continued growth.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Lyell Immunopharma (United States)
company in South San Francisco, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireLyell Immunopharma Announces up to $100 Million Equity Private Placement SOUTH SAN FRANCISCO, Calif., July 25, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage compa